2xx9
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='2xx9' size='340' side='right'caption='[[2xx9]], [[Resolution|resolution]] 1.97Å' scene=''> | <StructureSection load='2xx9' size='340' side='right'caption='[[2xx9]], [[Resolution|resolution]] 1.97Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2xx9]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[2xx9]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2XX9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2XX9 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1NF:N,N-DIMETHYL-4-[3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL]BENZAMIDE'>1NF</scene>, <scene name='pdbligand=GLU:GLUTAMIC+ACID'>GLU</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.97Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1NF:N,N-DIMETHYL-4-[3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL]BENZAMIDE'>1NF</scene>, <scene name='pdbligand=GLU:GLUTAMIC+ACID'>GLU</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2xx9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2xx9 OCA], [https://pdbe.org/2xx9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2xx9 RCSB], [https://www.ebi.ac.uk/pdbsum/2xx9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2xx9 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2xx9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2xx9 OCA], [https://pdbe.org/2xx9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2xx9 RCSB], [https://www.ebi.ac.uk/pdbsum/2xx9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2xx9 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
- | + | [https://www.uniprot.org/uniprot/GRIA2_RAT GRIA2_RAT] Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.<ref>PMID:9351977</ref> <ref>PMID:19265014</ref> <ref>PMID:21172611</ref> <ref>PMID:12501192</ref> <ref>PMID:12015593</ref> <ref>PMID:12872125</ref> <ref>PMID:12730367</ref> <ref>PMID:16192394</ref> <ref>PMID:15591246</ref> <ref>PMID:17018279</ref> <ref>PMID:16483599</ref> <ref>PMID:19946266</ref> <ref>PMID:21317873</ref> <ref>PMID:21846932</ref> | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 26: | Line 26: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Buffalo rat]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Aldegheri | + | [[Category: Rattus norvegicus]] |
- | [[Category: Austin | + | [[Category: Aldegheri L]] |
- | [[Category: Ballantine | + | [[Category: Austin NE]] |
- | [[Category: Ballini | + | [[Category: Ballantine S]] |
- | [[Category: Bax | + | [[Category: Ballini E]] |
- | [[Category: Bradley | + | [[Category: Bax BD]] |
- | [[Category: Clarke | + | [[Category: Bradley DM]] |
- | [[Category: DalNegro | + | [[Category: Clarke BP]] |
- | [[Category: Harries | + | [[Category: DalNegro G]] |
- | [[Category: Harris | + | [[Category: Harries M]] |
- | [[Category: Harrison | + | [[Category: Harris AJ]] |
- | [[Category: Melarange | + | [[Category: Harrison SA]] |
- | [[Category: Mookherjee | + | [[Category: Melarange RA]] |
- | [[Category: Mosley | + | [[Category: Mookherjee C]] |
- | [[Category: Oliosi | + | [[Category: Mosley J]] |
- | [[Category: Smith | + | [[Category: Oliosi B]] |
- | [[Category: Thewlis | + | [[Category: Smith KJ]] |
- | [[Category: Ward | + | [[Category: Thewlis KM]] |
- | [[Category: Woollard | + | [[Category: Ward SE]] |
- | [[Category: Yusaf | + | [[Category: Woollard PM]] |
- | + | [[Category: Yusaf SP]] | |
- | + | ||
- | + |
Current revision
Crystal structure of 1-((2-fluoro-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1H-indazol-1-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 2.2A resolution.
|
Categories: Large Structures | Rattus norvegicus | Aldegheri L | Austin NE | Ballantine S | Ballini E | Bax BD | Bradley DM | Clarke BP | DalNegro G | Harries M | Harris AJ | Harrison SA | Melarange RA | Mookherjee C | Mosley J | Oliosi B | Smith KJ | Thewlis KM | Ward SE | Woollard PM | Yusaf SP